Treatment of various HNSCC cell lines with IGF1R and Src inhibitors in combination resulted in robust synergy in 8 of the 9 cell lines tested with growth inhibition of at least 49%5. The gene discussed is IGF1R; the disease is head and neck squamous cell carcinoma.